tiprankstipranks
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market
Holding DSGN?
Track your performance easily

Design Therapeutics (DSGN) Stock Investors

82 Followers
Based on 775,913 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DSGN
On average, investors allocate 0.00% of their portfolios to DSGN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 775,913 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding DSGN

1.9%
Last 7
Days
11.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DSGN, out of 775,913 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

DSGN Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,803 investors who made their portfolios public
The table shows changes in DSGN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

DSGN Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
AppLovin
6.17%
-0.97%
+8.21%
114.43B
Technology
UiPath
3.43%
-0.13%
+1.75%
7.28B
Technology
DraftKings
5.17%
-0.84%
-0.23%
35.53B
Consumer Cyclical
Plug Power
5.25%
-1.69%
-1.16%
2.33B
Industrials
Viking Therapeutics
4.22%
-1.19%
+0.59%
4.71B
Healthcare
RTX
3.98%
-0.11%
+4.02%
155.04B
Industrials
Delta Air Lines
5.42%
>-0.01%
+2.91%
39.32B
Industrials
Marathon Digital Holdings
5.56%
+0.50%
+5.72%
6.42B
Financial
JD
4.97%
-1.76%
+1.37%
56.19B
Consumer Cyclical
C3ai
6.47%
+0.26%
+7.38%
4.69B
Technology
Based on the activity of 775,913 active portfolios
Open your Smart Portfolio

DSGN Investor Analysis

DSGN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
33.3%
of DSGN holders
are under 35
Average Segment Performance
Average P/E Ratio31.02
Beta11.19
Dividend Yield3.79%
DSGN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
44.4%
of DSGN holders
are between 35–55
Average Segment Performance
Average P/E Ratio27.81
Beta21.08
Dividend Yield3.33%
DSGN investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
22.2%
of DSGN holders
are over 55
Average Segment Performance
Average P/E Ratio26.04
Beta9.79
Dividend Yield3.54%
Overview of age group and performance of DSGN stock investors
See who invests in DSGN according to age group and performance.

FAQ

How many retail Investors hold DSGN?
<0.1% of TipRanks' retail investors hold DSGN in their portfolios.
    What is DSGN Investor Sentiment?
    DSGN’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DSGN in the last 7 days?
      ▼ 1.9% of TipRanks' retail investors changed their holding of DSGN in the last 7 days.
        What percentage of retail investors changed their holding of DSGN in the last 30 days?
        ▼ 11.6% of TipRanks' retail investors changed their holding of DSGN in the last 30 days.
          What is the average age of retail investors who hold DSGN?
          The average age of DSGN Holders is between 35–55.
            What other stocks have DSGN investors also bought?
            DSGN Investors also bought APP, PATH, DKNG, PLUG, VKTX, RTX, DAL, MARA, JD, AI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BDXBecton Dickinson
              BIIBBiogen
              LCTXLineage Therap
              BMYBristol-Myers Squibb
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis